OBJECTIVE To investigate whether quinolinic acid(QA)induces autophagy in PC12 cells and its relationship with glycogen synthase kinase-3β(GSK-3β)/β-catenin related signaling path?ways. METHODS PC12 cells were treated with QA 2.5,5.0 and 10.0 mmol·L-1 for 24 h. The cell viability was determined by MTT assay. Autophagy fluorescent spots labelled form of microtubule-associated protein 1 light chain 3(LC3)was examined by LC3 immunostaining. The expressions of GSK-3β,β-catenin,LC3 and Beclin 1 were determined by Western blotting. RESULTS QA inhibited PC12 cell survival in a concentration-dependent manner,and IC50 was 8.7 mmol · L- 1. Compared with normal control group,QA 2.5,5.0 and 10.0 mmol · L-1 increased autophagic intracellular LC3 fluorescence spots,elevated the expression ratio of LC3-Ⅱ/LC3-Ⅰ and expression of Beclin 1 in PC12 cells(P<0.05). In addition,QA enhanced GSK-3βexpression and decreasedβ-catenin expression(P<0.05,P<0.01). CONCLUSION QA induces autophagy in PC12 cells. This mechanism may be associated with the activation of GSK-3β/β-catenin related signaling pathways.

Objective To explore the influence factors of the metabolic syndrome in the continuous ambu-latory peritoneal peptide(CAPD)patients. Methods A total of 104 CAPD in the PD center of the First and the Second Affiliated Hospital of Guangxi Medical University from June 2014 to June 2016 were enrolled in this study. Patients were divided into the metabolic syndrome(MS)and the non-metabolic syndrome(non-MS)group. The clinical data of patients with MS and non-MS was compared,and the influence factors of the MS in PD patients were analyzed. Results Twelve patients were diagnosed as metabolic syndrome. Significant differences in age, urine volume,serum phosphorus(P)and uric acid(UA)were observed between group MS and non-MS(P<0.05). Twenty people were overweight,with the prevalence rate of 19.2%. Compared with the normal and overweight group,age,high density lipoprotein(HDL),P and serum iron were statistically significant(P < 0.05). Thirty-one people were diagnosed as dyslipidemia,with the prevalence rate of 29.8%. Compared with the normal group, albumin,UA,BMI and D/P were statistically significant in the dyslipidemia group(P < 0.05). Ten patients were diagnosed as hyperglycemia,with the prevalence rate of 9.6 %. Significant differences in hemoglobin and the dia-stolic blood pressure(DBP)were found between the hyperglycemia group and the normal group(P < 0.05). Age and P were shown as independent risk factors for PD patients with MS(P<0.05,respectively).Conclusion The peritoneal dialysis patients were more likely to have metabolic syndrome than the normal population.Age and serum phosphorus are the factors influencing the occurrence of MS in peritoneal dialysis patients.